Abstract:AIM: To investigate the role of Rho-associated protein kinase (ROCK) inhibitor, Y2763Z in mediating the production of extracellular matrix (ECM) components including fibronectin, matrix metallo -proteinase -2 (MMP -2) and type I collagen as induced by connective tissue growth factor(CTGF) or transforming growth factor-beta (TGF-beta) in a human retinal pigment epithelial cell line, ARPE-19.METHODS: The effect of Y27632 on the CTGF or TGF-beta induced phenotype in ARPE-19 cells was measured with immunocytochemistry as the change in F-actin. ARPE-19 cells were treated with CTGF (1, 10, 100ng/mL)and TGF-beta (10ng/mL) in serum free media, and analyzed for fibronectin, laminin, and MMP -2 and type I collagen by RT -qPCR and immunocytochemistry. Cells were also pretreated with an ROCK inhibitor, Y27632, to analyze the signaling contributing to ECM production.RESULTS: Treatment of ARPE-19 cells in culture with TGF -beta or CTGF induced an ECM change from a cobblestone morphology to a more elongated swirl pattern indicating a mesenchymal phenotype. RT-qPCR analysis and different gene expression analysis demonstrated an upregulation in expression of genes associated with cytoskeletal structure and motility. CTGF or TGF-beta significantly increased expression of fibronectin mRNA (P=0.006, P=0.003 respectively), laminin mRNA (P=0.006, P=0.005), MMP-2 mRNA (P=0.006, P=0.001), COL1A1 mRNA (P=0.001, P=0.001), COL1A2 mRNA (P= 0.001, P=0.001). Preincubation of ARPE-19 with Y27632 (10 mmol/L)significantly prevented CTGF or TGF-beta induced fibronectin (P=0.005, P=0.003 respectively), MMP-2 (P= 0.003, P=0.002), COL1A1 (P =0.006, P =0.003), and COL1A2 (P=0.006, P=0.004) gene expression, but not laminin (P=0.375, P=0.516). "CONCLUSION: Our study demonstrated that both TGF-beta and CTGF upregulate the expression of ECM components including fibronectin, laminin, MMP -2 and type I collagen by activating the RhoA/ROCK signaling pathway. During this process, ARPE -19 cells were shown to change from an epithelial to a mesenchymal phenotype in vitra Y27632, a ROCK inhibitor, inhibited the transcription of fibronectin, MMP -2 and type I collagen, but not laminin. The data from our work suggest a role for CTGF as a profibrotic mediator. Inhibiting the RhoA/ROCK pathway represents a potential target to prevent the fibrosis of retinal pigment epithelial (RPE) cells. This might lead to a novel therapeutic approach to preventing the onset of early proliferative vitreoretinopathy(PVR).

Y-39983 downregulates RhoA/Rho-associated kinase expression during its promotion of axonal regeneration.

Rho-associated Kinase Inhibitor, Y-27632, Inhibits the Invasion and Proliferation of T24 and 5367 Bladder Cancer Cells

Inhibition of Rho-kinase differentially affects axon regeneration of peripheral motor and sensory nerves

Erythropoietin promotes axonal regeneration after optic nerve crush in vivo by inhibition of RhoA/ROCK signaling pathway.

Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo

RhoA Activation and Effect of Rho-kinase Inhibitor in the Development of Retinal Neovascularization in a Mouse Model of Oxygen-induced Retinopathy

Rho Kinase Inhibitor Y27632 Improves Recovery after Spinal Cord Injury by Shifting Astrocyte Phenotype and Morphology Via the ROCK/NF-κB/C3 Pathway

Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates

Inhibition Of Rhoa/Rho-Kinase Pathway Suppresses The Expression Of Extracellular Matrix Induced By Ctgf Or Tgf-Beta In Arpe-19

Sema3A inhibits axonal regeneration of retinal ganglion cells via ROCK2

Rho/Rho-associated Kinase Pathway in Glaucoma (Review).

Protection of Photoreceptors by Intravitreal Injection of the Y-27632 Rho-associated Protein Kinase Inhibitor in Royal College of Surgeons Rats.

The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar

Activation of Rho after spinal cord injury and the collapse of growth cone

The Role of Ras Homolog Family/ras Homolog Family Kinase Signaling Pathway and Its Inhibitors in the Optic Nerve Disease

Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops

ROK and Neuron Ischemia and Ischemia-Reperfusion Injury Inducing Collapse of Axon in Vitro

Rho signaling pathway targeted to promote spinal cord repair

Rho-Associated Kinase Inhibitors Promote Microglial Uptake Via the ERK Signaling Pathway

Involvement of Rho-associated Coiled-Coil Kinase Signaling Inhibition in TGF-β1/Smad2, 3 Signal Transduction in Vitro

Protective Effects of Intravitreal Injection of the Rho-Kinase Inhibitor Y-27632 in a Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy (Raion)